Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.
DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.
Here, we describe a method to isolate and grow normal human mammary epithelial cells (HMECs) from reduction mammoplasty specimens in vivo. The introduction of primary breast epithelial cells directly into the milk ducts of immunocompromised mice, enables their engraftment within the epithelial-rich ductal microenvironment where they maintain their epithelial identity and response to hormonal stimuli. Taking advantage of traceable in-vivo fluorescent and luciferase reporters, this approach can be readily be used as an in vivo platform for toxicity testing to study the effect of hormonal contraceptives, endocrine-disrupting chemicals and environmental toxins on the normal breast epithelium and breast cancer cells. Downstream analyses using human-specific techniques enable histological characterization and pathway analyses within a clinically relevant humanized in vivo model of the breast epithelium.